Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Plasma cell 1

Conditions

Leukemia, Myeloid, Acute 122Precursor Cell Lymphoblastic Leukemia-Lymphoma 108Myelodysplastic Syndromes 97Lymphoma, Non-Hodgkin 88Leukemia, Lymphocytic, Chronic, B-Cell 81Hodgkin Disease 81Multiple Myeloma 80Leukemia 72Lymphoma, Mantle-Cell 62Lymphoma, Follicular 58Lymphoma 55Leukemia, Myelogenous, Chronic, BCR-ABL Positive 55Myeloproliferative Disorders 52Lymphoma, B-Cell, Marginal Zone 52Lymphoma, Large B-Cell, Diffuse 48Burkitt Lymphoma 48Leukemia, Myelomonocytic, Chronic 47Congenital Abnormalities 41Hematologic Neoplasms 37Lymphoma, Large-Cell, Immunoblastic 35Leukemia, Myeloid, Accelerated Phase 34Waldenstrom Macroglobulinemia 33Leukemia, Myeloid, Chronic-Phase 33Anemia, Refractory, with Excess of Blasts 32Primary Myelofibrosis 31Blast Crisis 28Lymphoma, T-Cell, Cutaneous 27Lymphoma, Large-Cell, Anaplastic 26Leukemia, Biphenotypic, Acute 26Dendritic Cell Sarcoma, Interdigitating 26

Interventions

fludarabine phosphate 4Cyclophosphamide 3Whole-Body Irradiation 2Mycophenolic Acid 2Etoposide 2pevonedistat 1obinutuzumab 1nelarabine 1letermovir 1ibrutinib 1carmustine, poliferprosan 20 drug combination 1Tacrolimus 1Stem Cell Transplantation 1Specimen Handling 1Pharmacogenomic Variants 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Leukapheresis 1Hematopoietic Stem Cell Transplantation 1Cytarabine 1Cyclosporins 1Cyclosporine 1Carmustine 1Blood Component Removal 1Biopsy 1Bendamustine Hydrochloride 16-(1H-indazol-6-yl)-N-(4-morpholinophenyl)imidazo(1,2-a)pyrazin-8-amine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Leukemia, Prolymphocytic, B-Cell × Whole-Body Irradiation × Clear all
NCT01008462 2019-06-11

Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
16 enrolled 15 charts
LymphoidOther hematologic neoplasmPlasma cell

Chromosome 17 deletion, Hodgkin Disease, Leukemia, Plasma Cell, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Multiple Myeloma, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, B-Cell

NCT00060424 2017-12-08

Fludarabine Phosphate and Total-Body Irradiation Before Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia

Fred Hutchinson Cancer Center

Phase 2 Completed
21 enrolled 13 charts
LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Prolymphocytic, T-Cell, Leukemia, Prolymphocytic, Leukemia, Prolymphocytic, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡